ATNF
Price
$1.87
Change
+$0.01 (+0.54%)
Updated
Dec 23 closing price
BDRX
Price
$3.82
Change
-$0.17 (-4.26%)
Updated
Dec 23 closing price
Ad is loading...

ATNF vs BDRX

Header iconATNF vs BDRX Comparison
Open Charts ATNF vs BDRXBanner chart's image
180 Life Sciences
Price$1.87
Change+$0.01 (+0.54%)
Volume$43.07K
CapitalizationN/A
Biodexa Pharmaceuticals
Price$3.82
Change-$0.17 (-4.26%)
Volume$20.77K
CapitalizationN/A
ATNF vs BDRX Comparison Chart
Loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNF vs. BDRX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNF is a Hold and BDRX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Dec 24, 2024
Stock price -- (ATNF: $1.87 vs. BDRX: $3.82)
Brand notoriety: ATNF and BDRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNF: 7% vs. BDRX: 10%
Market capitalization -- ATNF: $3.8M vs. BDRX: $2.27M
ATNF [@Biotechnology] is valued at $3.8M. BDRX’s [@Biotechnology] market capitalization is $2.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNF’s FA Score shows that 0 FA rating(s) are green whileBDRX’s FA Score has 1 green FA rating(s).

  • ATNF’s FA Score: 0 green, 5 red.
  • BDRX’s FA Score: 1 green, 4 red.
According to our system of comparison, BDRX is a better buy in the long-term than ATNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNF’s TA Score shows that 5 TA indicator(s) are bullish while BDRX’s TA Score has 4 bullish TA indicator(s).

  • ATNF’s TA Score: 5 bullish, 4 bearish.
  • BDRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ATNF is a better buy in the short-term than BDRX.

Price Growth

ATNF (@Biotechnology) experienced а +2.75% price change this week, while BDRX (@Biotechnology) price change was -7.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.75%. For the same industry, the average monthly price growth was -2.52%, and the average quarterly price growth was +3.67%.

Reported Earning Dates

ATNF is expected to report earnings on Mar 01, 2023.

BDRX is expected to report earnings on Nov 30, 2022.

Industries' Descriptions

@Biotechnology (-1.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNF($3.8M) has a higher market cap than BDRX($2.27M). ATNF YTD gains are higher at: -53.901 vs. BDRX (-94.299).
ATNFBDRXATNF / BDRX
Capitalization3.8M2.27M168%
EBITDA-2.99MN/A-
Gain YTD-53.901-94.29957%
P/E Ratio0.23N/A-
Revenue0N/A-
Total Cash195KN/A-
Total Debt3.26MN/A-
FUNDAMENTALS RATINGS
ATNF vs BDRX: Fundamental Ratings
ATNF
BDRX
OUTLOOK RATING
1..100
391
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6365
P/E GROWTH RATING
1..100
8195
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDRX's Valuation (21) in the Biotechnology industry is somewhat better than the same rating for ATNF (56) in the Financial Conglomerates industry. This means that BDRX’s stock grew somewhat faster than ATNF’s over the last 12 months.

BDRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATNF (100) in the Financial Conglomerates industry. This means that BDRX’s stock grew similarly to ATNF’s over the last 12 months.

BDRX's SMR Rating (99) in the Biotechnology industry is in the same range as ATNF (99) in the Financial Conglomerates industry. This means that BDRX’s stock grew similarly to ATNF’s over the last 12 months.

ATNF's Price Growth Rating (63) in the Financial Conglomerates industry is in the same range as BDRX (65) in the Biotechnology industry. This means that ATNF’s stock grew similarly to BDRX’s over the last 12 months.

ATNF's P/E Growth Rating (81) in the Financial Conglomerates industry is in the same range as BDRX (95) in the Biotechnology industry. This means that ATNF’s stock grew similarly to BDRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNFBDRX
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
85%
Bullish Trend 22 days ago
78%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THCH0.730.05
+6.91%
TH International Limited
HEPA0.500.01
+2.02%
Hepion Pharmaceuticals
UNM72.780.77
+1.07%
Unum Group
GMRE7.80-0.06
-0.76%
Global Medical REIT
CMPR73.40-0.81
-1.09%
Cimpress plc

ATNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNF has been loosely correlated with PRQR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNF jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNF
1D Price
Change %
ATNF100%
+0.54%
PRQR - ATNF
48%
Loosely correlated
+1.52%
CTCX - ATNF
43%
Loosely correlated
+2.36%
JSPR - ATNF
41%
Loosely correlated
+2.55%
WVE - ATNF
39%
Loosely correlated
-2.89%
KRRO - ATNF
37%
Loosely correlated
-0.87%
More

BDRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with LVTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
-4.26%
LVTX - BDRX
41%
Loosely correlated
-4.49%
ATNF - BDRX
36%
Loosely correlated
+0.54%
SCNI - BDRX
32%
Poorly correlated
-1.47%
AVTX - BDRX
32%
Poorly correlated
+2.02%
ATXI - BDRX
31%
Poorly correlated
+1.69%
More